Healthcare / Medical Care FacilitiesNasdaqCM
$8.69
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $8.2M · quality 50.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
5/100
F
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$124M
P/E
N/A
•EV/EBITDA
N/A
•ROE
19.3%
↑Gross Margin
N/A
•Debt/Equity
N/A
•Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2013–2025 · 12 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
—
FCF / Net income
0.12x
Latest source
Provider fallback
Margin decomposition
Último año: revenue — · net income $2.9M · FCF $334724.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | — | — | — | $117.7M | $101.3M | $80.0M | $58.7M | $48.5M | $36.7M | $24.9M | $20.5M | $13.8M | $7.1M | $6.0M |
| Net Income | $2.9M | $2.9M | $-5.8M | $-9.8M | $626705.00 | $7.6M | $13.2M | $3.3M | $146696.00 | $-3.4M | $-15.2M | $-8.8M | $-3.0M | $155635.00 |
| EBITDA | $800343.00 | $800343.00 | $2.8M | $8.9M | $4.8M | $10.0M | $8.2M | $5.3M | $1.7M | $-1.3M | $-12.4M | $-8.0M | $-1.4M | $510514.00 |
| EPS | 0.19 | 0.19 | -0.38 | -0.65 | -0.38 | 0.51 | 0.90 | 0.23 | 0.01 | -0.26 | — | — | -0.56 | 0.02 |
| Operating Margin | — | — | — | 0.3% | -1.9% | 7.7% | 9.4% | 7.0% | 0.4% | -13.4% | -73.1% | -67.3% | -22.9% | 7.4% |
| Net Margin | — | — | — | -8.3% | 0.6% | 9.5% | 22.4% | 6.9% | 0.4% | -13.8% | -73.9% | -63.6% | -42.6% | 2.6% |
| Balance Sheet | ||||||||||||||
| Debt/Equity | — | — | — | — | — | — | — | — | — | 0.09 | 0.05 | 0.03 | — | — |
| Cash Flow | ||||||||||||||
| Free Cash Flow | $334724.00 | $334724.00 | $8.2M | $9.7M | $2.3M | $6.9M | $8.0M | $4.0M | $4.3M | $-523335.00 | $-12.4M | — | — | — |
| Returns | ||||||||||||||
| ROE | 19.3% | 19.3% | -28.1% | -39.4% | 1.9% | 25.0% | 62.3% | 58.1% | 20.2% | -297.6% | -219.1% | -42.5% | -19.4% | -12.7% |
| Growth & Yield | ||||||||||||||
| Revenue Growth | — | — | — | 16.2% | 26.5% | 36.3% | 21.1% | 32.2% | 47.1% | 21.4% | 48.3% | 94.4% | 19.4% | — |
| EPS Growth | 150.0% | 150.0% | 41.5% | -71.1% | -174.5% | -43.3% | 291.3% | 2200.0% | 103.8% | — | — | — | -2900.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
59.5%
EPS terminal req.
$0.77
Spread vs growth
90.5%
5Y implied EPS CAGR
37.5%
EPS terminal req.
$0.93
Spread vs growth
112.5%
10Y implied EPS CAGR
23.0%
EPS terminal req.
$1.50
Spread vs growth
127.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.